Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Equity Income (2016 - 2025)

Surgery Partners (SGRY) has disclosed Equity Income for 12 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Equity Income fell 8.33% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2025, up 17.44% year-over-year, with the annual reading at $22.9 million for FY2025, 17.44% up from the prior year.
  • Equity Income hit $6.6 million in Q4 2025 for Surgery Partners, up from $5.2 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $7.2 million in Q4 2024 to a low of $2.4 million in Q3 2022.
  • Historically, Equity Income has averaged $4.0 million across 5 years, with a median of $3.4 million in 2023.
  • Biggest five-year swings in Equity Income: dropped 18.18% in 2024 and later soared 107.41% in 2025.
  • Year by year, Equity Income stood at $2.8 million in 2021, then skyrocketed by 57.14% to $4.4 million in 2022, then increased by 9.09% to $4.8 million in 2023, then skyrocketed by 50.0% to $7.2 million in 2024, then fell by 8.33% to $6.6 million in 2025.
  • Business Quant data shows Equity Income for SGRY at $6.6 million in Q4 2025, $5.2 million in Q3 2025, and $5.5 million in Q2 2025.